Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne M Mills

Showing results (11-20 of 109) with videos related to

Pageof 11
Sort By:
Seminars in Diagnostic Pathology|February 12, 2011
Endometrial hyperplasiaAnne M Mills, Teri A Longacre
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|March 30, 2021
The Immune Checkpoint Inhibitor LAG-3 and Its Ligand GAL-3 in Vulvar Squamous NeoplasiaMargaret M Cocks, Anne M Mills
Surgical Pathology Clinics|June 1, 2016
Lynch Syndrome: Female Genital Tract Cancer Diagnosis and ScreeningAnne M Mills, Teri A Longacre
The American Journal of Surgical Pathology|November 10, 2015
Predictive Value of Cytokeratin 7 Immunohistochemistry in Cervical Low-grade Squamous Intraepithelial Lesion as a Marker for Risk of Progression to a High-grade LesionCherie Paquette, Anne M Mills, Mark H Stoler
Gynecologic Oncology Reports|June 13, 2018
PD-L1 pitfalls: Emphasizing the importance of membranous localization and correlation with tumor cell and macrophage distributionsAnne M Mills, Chelsea Gottlieb, Kari L Ring
Histopathology|August 2, 2018
PD-L1 and IDO expression in cervical and vulvar invasive and intraepithelial squamous neoplasias: implications for combination immunotherapyZachary Chinn, Mark H Stoler, Anne M Mills
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 5, 2026
Endometrial Carcinoma of Gastrointestinal-type (EMCG): Incidence, Molecular Features, and Distinction From Other Endometrial Cancers With Gastrointestinal Marker ImmunoexpressionEyas Alzayadneh, Vanessa L Smith, Anne M Mills
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 19, 2019
Expression of the Immune Checkpoints LAG-3 and PD-L1 in High-grade Serous Ovarian Carcinoma: Relationship to Tumor-associated Lymphocytes and Germline BRCA StatusRachel Whitehair, Lauren C Peres, Anne M Mills
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 31, 2019
TIM-3 in endometrial carcinomas: an immunotherapeutic target expressed by mismatch repair-deficient and intact cancersMargaret Moore, Kari L Ring, Anne M Mills
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|May 5, 2022
PRAME Expression in Endometrioid and Serous Endometrial Carcinoma: A Potential Immunotherapeutic Target and Possible Diagnostic PitfallJoseph D Coppock, Sarah E Gradecki, Anne M Mills
Pageof 11

Showing results (11-20 of 109) with videos related to

Sort By:
Pageof 11
Seminars in Diagnostic Pathology|February 12, 2011
Endometrial hyperplasiaAnne M Mills, Teri A Longacre
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|March 30, 2021
The Immune Checkpoint Inhibitor LAG-3 and Its Ligand GAL-3 in Vulvar Squamous NeoplasiaMargaret M Cocks, Anne M Mills
Surgical Pathology Clinics|June 1, 2016
Lynch Syndrome: Female Genital Tract Cancer Diagnosis and ScreeningAnne M Mills, Teri A Longacre
The American Journal of Surgical Pathology|November 10, 2015
Predictive Value of Cytokeratin 7 Immunohistochemistry in Cervical Low-grade Squamous Intraepithelial Lesion as a Marker for Risk of Progression to a High-grade LesionCherie Paquette, Anne M Mills, Mark H Stoler
Gynecologic Oncology Reports|June 13, 2018
PD-L1 pitfalls: Emphasizing the importance of membranous localization and correlation with tumor cell and macrophage distributionsAnne M Mills, Chelsea Gottlieb, Kari L Ring
Histopathology|August 2, 2018
PD-L1 and IDO expression in cervical and vulvar invasive and intraepithelial squamous neoplasias: implications for combination immunotherapyZachary Chinn, Mark H Stoler, Anne M Mills
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|February 5, 2026
Endometrial Carcinoma of Gastrointestinal-type (EMCG): Incidence, Molecular Features, and Distinction From Other Endometrial Cancers With Gastrointestinal Marker ImmunoexpressionEyas Alzayadneh, Vanessa L Smith, Anne M Mills
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 19, 2019
Expression of the Immune Checkpoints LAG-3 and PD-L1 in High-grade Serous Ovarian Carcinoma: Relationship to Tumor-associated Lymphocytes and Germline BRCA StatusRachel Whitehair, Lauren C Peres, Anne M Mills
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 31, 2019
TIM-3 in endometrial carcinomas: an immunotherapeutic target expressed by mismatch repair-deficient and intact cancersMargaret Moore, Kari L Ring, Anne M Mills
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|May 5, 2022
PRAME Expression in Endometrioid and Serous Endometrial Carcinoma: A Potential Immunotherapeutic Target and Possible Diagnostic PitfallJoseph D Coppock, Sarah E Gradecki, Anne M Mills
Pageof 11